Does the Number of Neoadjuvant Chemotherapy Cycles before Interval Debulking Surgery Influence Survival in Advanced Ovarian Cancer?

Publisher： Karger

E-ISSN： 1423-0232|91|6|331-340

ISSN： 0030-2414

Source： Oncology, Vol.91, Iss.6, 2016-10, pp. : 331-340

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Surgical Debulking Before or After Chemotherapy: Stemming the Tide on Ovarian Cancer Recurrence

By  

Oncology Research and Treatment, Vol. 33, Iss. 6, 2010-05 ,pp. : 286-287

Karger

Access to resources Recommend Favorite

The Role of Neoadjuvant Chemotherapy in the Treatment of Advanced Ovarian Cancer

By  

Oncology, Vol. 68, Iss. 1, 2005-04 ,pp. : 64-70

Karger

Access to resources Recommend Favorite

Oncologic Concerns regarding Laparoscopic Cytoreductive Surgery in Patients with Advanced Ovarian Cancer Submitted to Neoadjuvant Chemotherapy

By  

Oncology, Vol. 89, Iss. 3, 2015-05 ,pp. : 159-166

Karger

Access to resources Recommend Favorite

Residual Cancer Stem Cells after Interval Cytoreductive Surgery following Neoadjuvant Chemotherapy Could Result in Poor Treatment Outcomes for Ovarian Cancer

By  

Oncology Research and Treatment, Vol. 33, Iss. 6, 2010-05 ,pp. : 324-330

Karger

Access to resources Recommend Favorite

Interval Debulking Surgery in Patients with Federation of Gynecology and Obstetrics (FIGO) Stage IIIC and IV Ovarian Cancer

By  

Oncology Research and Treatment, Vol. 36, Iss. 6, 2013-05 ,pp. : 324-332

Karger

Access to resources Recommend Favorite